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Brain arteriovenous malformations (AVMs) are congenital abnormalities that consist of direct con-nections between arteries and veins, allowing high-
pressure arterial blood to flow into fragile cerebral veins, 
resulting in a high risk of hemorrhagic stroke.16,37 The aim 
of AVM treatment is to prevent hemorrhage.29 Treatment 
is effective only with complete AVM removal or oblitera-
tion.14 Current treatments—namely surgery, endovascular 
occlusion, or stereotactic radiosurgery—are all associated 
with significant limitations.1,42 The surgical risk is gen-
erally unacceptable for lesions that are large, located in 
critical brain structures, or involve deep perforating arter-
abbreviations AVM = arteriovenous malformation; FWD = forward; PI = propidium iodide; PS = phosphatidylserine; pSIVA = polarity-sensitive indicator of viability and 
apoptosis; SRS = stereotactic radiosurgery.
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obJect Stereotactic radiosurgery (SRS) is an established intervention for brain arteriovenous malformations (AVMs). 
The processes of AVM vessel occlusion after SRS are poorly understood. To improve SRS efficacy, it is important to un-
derstand the cellular response of blood vessels to radiation. The molecular changes on the surface of AVM endothelial 
cells after irradiation may also be used for vascular targeting. This study investigates radiation-induced externalization of 
phosphatidylserine (PS) on endothelial cells using live-cell imaging.
methods An immortalized cell line generated from mouse brain endothelium, bEnd.3 cells, was cultured and irradi-
ated at different radiation doses using a linear accelerator. PS externalization in the cells was subsequently visualized 
using polarity-sensitive indicator of viability and apoptosis (pSIVA)-IANBD, a polarity-sensitive probe. Live-cell imaging 
was used to monitor PS externalization in real time. The effects of radiation on the cell cycle of bEnd.3 cells were also 
examined by flow cytometry.
results Ionizing radiation effects are dose dependent. Reduction in the cell proliferation rate was observed after 
exposure to 5 Gy radiation, whereas higher radiation doses (15 Gy and 25 Gy) totally inhibited proliferation. In compari-
son with cells treated with sham radiation, the irradiated cells showed distinct pseudopodial elongation with little or no 
spreading of the cell body. The percentages of pSIVA-positive cells were significantly higher (p = 0.04) 24 hours after 
treatment in the cultures that received 25- and 15-Gy doses of radiation. This effect was sustained until the end of the 
experiment (3 days). Radiation at 5 Gy did not induce significant PS externalization compared with the sham-radiation 
controls at any time points (p > 0.15). Flow cytometric analysis data indicate that irradiation induced growth arrest of 
bEnd.3 cells, with cells accumulating in the G2 phase of the cell cycle.
conclusions Ionizing radiation causes remarkable cellular changes in endothelial cells. Significant PS externaliza-
tion is induced by radiation at doses of 15 Gy or higher, concomitant with a block in the cell cycle. Radiation-induced 
markers/targets may have high discriminating power to be harnessed in vascular targeting for AVM treatment.
http://thejns.org/doi/abs/10.3171/2015.4.JNS142129
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ies. Endovascular treatment is usually not able to achieve 
a complete obliteration and is used to facilitate surgery 
rather than attempt cure.1
Stereotactic radiosurgery (SRS), a technique to deliv-
er focused ionizing radiation to the AVM tissues in the 
brain, has been widely used to treat these patients.11,30 SRS 
can focus on the targeted nidus precisely, with only neg-
ligible amounts of radiation delivered to the surrounding 
brain tissue.30 The margin dose of the radiation is typically 
16–25 Gy, depending on the nidus size, location, shape, 
and proximity to critical structures.10,44 Occlusion rates 
are generally greater than 70%.44 
The purpose of SRS for AVMs is to occlude the blood 
vessels. The processes of AVM vessel occlusion after 
radiosurgery are poorly understood but are believed to 
involve a combination of cellular proliferation and intra-
vascular thrombosis.3,36 Unfortunately, there is a delay 
to occlusion of 2–3 years after treatment and the risk of 
hemorrhage is not reduced until complete obliteration oc-
curs.12,13 Another problem with SRS is that the radiation 
dose must be selected carefully so that it is not too high, 
which may cause radiation-induced injury to surrounding 
tissues, or too low, which may not be sufficient to cause 
obliteration of the vessels.9 Although SRS scoring systems 
have been developed and validated in clinical practice,31 
understanding the biological response of endothelium to 
radiation may permit a more accurate prediction of SRS 
outcomes. Radiation-induced changes in some cells, such 
as cancer cells, have been investigated;17,18,34 however, the 
relevant studies in brain endothelial cells are limited, es-
pecially at the molecular level.
The molecular changes on the surface of AVM endo-
thelial cells after radiation treatment may also be used as 
targets for vascular targeting (i.e., delivering thrombotic 
agents selectively to AVM sites by targeting markers on 
these cells, with the goal of obliterating the AVM vessels 
rapidly by inducing thrombosis).25,33,38 A highly discrimi-
nating target, which dominantly expresses on AVM en-
dothelium, is required for the success of this technique. 
We have investigated the molecular characteristics of the 
endothelial surface of AVM vessels20,39,40 and, although 
differences were found in comparison with normal blood 
vessels, no target with adequate discriminating power has 
been found to date. However, radiation-induced molecular 
changes on the endothelial surface may be a promising 
source of targets for vascular targeting.4 Due to its abil-
ity to deliver precisely focused radiation beams, the SRS-
induced molecular changes can be restricted within the 
AVMs.
It is well known that ionizing radiation can cause DNA 
damage and may lead to cell apoptosis.35 Cell damage 
can induce phosphatidylserine (PS) externalization on 
the membrane.7,26 Indeed, PS has been widely used as a 
marker of cell injury.26 Results of our previous work indi-
cated that PS was externalized selectively in the AVM ni-
dus after radiosurgery in an AVM animal model and that 
PS is a potential molecular target for vascular targeting.38 
More comprehensive study of PS externalization after ra-
diosurgery is required to reveal the molecular response of 
endothelial cells induced by radiation and its feasibility as 
a target for vascular targeting.
The conventional way to study PS externalization is 
to use fluorescently labeled annexin V, a protein that se-
lectively binds to PS as a reporter molecule. Normally, 
cultured cells or tissue slides are stained with annexin 
conjugates and the cells analyzed by microscopy or flow 
cytometry.26 However, because PS is a constructional lipid 
component of the cell membrane that is normally located 
on the inner surface of the membrane, many experimen-
tal treatments, such as harvest or fixation, can cause PS 
externalization.43,45 Hence, the results may not be reliable. 
Advances in microscopy have led to the development of 
live-cell imaging in recent years,32 and this represents an 
ideal method to observe PS externalization, because cell 
staining and monitoring are performed during culture. 
The technique allows for the visual detection of dynamic 
changes of PS externalization in real time after stimula-
tion. Furthermore, it is a simple technique in which cells 
do not require any treatment except for the addition of 
fluorescently conjugated annexin V into culture medium.
Since the fluorescently labeled annexin V is added to 
the medium and kept there during the monitoring period 
without any washing steps, it is possible that background 
fluorescence from the dye affects the detection sensitiv-
ity.15 Recently, polarity-sensitive indicator of viability and 
apoptosis (pSIVA)-IANBD, an annexin-based, polarity-
sensitive dye for PS, has become available.22 This indica-
tor has no fluorescence in solution; however, it fluoresces 
strongly upon binding to PS on the cell surface, because 
of the change of its microenvironment from aqueous solu-
tion to lipid cell membrane, and this binding is reversible. 
In the absence of PS on the cell surface, the dye is un-
bound (in solution); therefore, no background fluorescence 
is emitted, eliminating the need to wash out the unbound 
dye. This makes it ideal for live-cell imaging of PS exter-
nalization. In this paper, we report our results of PS exter-
nalization of mouse brain endothelial cells after radiosur-




Black, 96-well cell-culture plates with a flat and clear 
bottom were obtained from Ibidi GmbH. The bEnd.3 cells 
were from the American Type Culture Collection, and 
pSIVA-IANBD apoptosis/viability microscopy kits were 
purchased from Imgenex. Attachment factor for cell cul-
ture was a product of Cell Systems. DMEM, fetal bovine 
serum (FBS), and 1% penicillin/streptomycin were from 
Invitrogen.
cell culture
bEnd.3 cells, an immortalized cell line generated from 
mouse brain endothelium,28 were grown according to the 
supplier’s instructions in high-glucose DMEM containing 
10% FBS, 4.5 g/L glucose, 3.7 g/L sodium bicarbonate, 4 
mM glutamine, 100 U/ml penicillin, and 100 mg/ml strep-
tomycin, at a pH of 7.4. Cells were maintained in a hu-
mid chamber at 37°C in an atmosphere of 95% air and 5% 
carbon dioxide in 75-cm2 tissue-culture flasks. Confluent 
flasks were trypsinized and around 0.2% of the cells in 
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300 μl culture medium were seeded into individual wells 
(with a culture area of 0.55 cm2) of a 96-well cell-culture 
plate precoated with attachment factor. The cells were al-
lowed to grow for 1 day (about 20%–30% confluence) be-
fore undergoing irradiation.
cell irradiation
A linear accelerator (LINAC; Elekta AB) at Macqua-
rie University Hospital was used to irradiate the cells. The 
96-well plate was CT scanned and a radiation-dose dis-
tribution was planned on the Elekta XiO planning system 
to deliver a differential dose (25 Gy, 15 Gy, 5 Gy, and < 
0.5 Gy) to each of the 4 quadrants of the 96-well plate. Ir-
radiation of the cells was carried out using 6-MV photons 
from anterior- and posterior-directed radiation fields. The 
cells in the area that received < 0.5 Gy were treated as a 
sham-radiation control. The culture medium was changed 
just before irradiation.
live-cell imaging
After irradiation, the dyes pSIVA-IANBD (1.5 μl) 
and propidium iodide (PI, 0.75 μl), in the apoptosis/vi-
ability microscopy kit, and the apoptosis-inducing agent 
camptothecin (final concentration 10 μM) were added 
to the corresponding wells. The 96-well plate containing 
the cells was then transferred to the automated stage of 
a Nikon Ti inverted epi-fluorescent microscope (Nikon 
Corp.) equipped with an environmental chamber set at 
37°C. Humidified 5% carbon dioxide was supplied to the 
wells for the duration of the experiment. A ×40 phase ob-
jective (NA0.6) was used to collect transmission images, 
while pSIVA was detected in the FITC fluorescent chan-
nel (Ex 485 Em 521/13) and PI was detected in the Texas 
Red channel (Ex 607 Em 607/18). Two fields of view were 
selected in each well of triplicate wells, generating 6 fields 
of view for each radiation-dose group. Images were taken 
every 30 minutes at each field of view for 72 hours. The 
first image was taken 4 hours after irradiation. The experi-
ment was repeated twice.
detection of ps externalization and cell death
Manual counting by 2 of the authors independently (1 
of whom was blinded to sample identity) of cell number 
and pSIVA- and PI-positive staining spots was performed 
in each of the 6 fields of view in each group to calculate 
the degrees of PS externalization and cell death for the 
cells exposed to different doses of radiation. Counting was 
performed on images taken at 4, 24, 49, and 74 hours after 
irradiation. The results shown are a representative analysis 
and are expressed as the ratios of positive counting/total 
cell number.
Flow cytometric analysis of cell cycle
bEnd.3 cells were seeded into 75-cm2 culture flasks, 
allowed to grow for 1 day (about 30% confluence), then 
irradiated using the linear accelerator, whereby cells re-
ceived either 5-, 15-, or 25-Gy dose of radiation. Control 
cells were not exposed to radiation. Cells were harvested 
3 days later, fixed in ice-cold 70% ethanol, and stained 
with PI (10 μl PI in 1 ml PBS containing 0.05% Triton 
X-100 and 100 μg ribonuclease A) for 30 minutes for de-
tection of DNA. Flow cytometry analysis of cell cycle was 
performed on an LSR Fortessa X-20 cytometer (Becton, 
Dickinson and Co.). Data were acquired with DIVA soft-
ware (version 8.1, Becton, Dickinson and Co.), collecting 
10,000 events per sample with PI area fluorescence de-
tected on a linear scale, and % forward (FWD)-area set to 
0.40. Data were analyzed with CellQuest Pro (version 6.0; 
Becton, Dickinson and Co.), and with Modfit LT (version 
3.2) for cell cycle analysis gating on single cells defined as 
those with proportional FWD-height versus FWD-area. 
The composite data figure was prepared using Adobe Il-
lustrator CS6 (version 16.0.0; Adobe Systems Inc.).
statistical analysis
Results are expressed as mean ± SD. Comparison of 
differences between test groups was made by unpaired 
two-tailed Student t-test. Differences were considered sig-
nificant at p < 0.05.
results
effect of radiation on cell proliferation
The cell confluence at the time of radiation treatment 
was 20%–30%, leaving enough room for the cells to pro-
liferate during the 3-day incubation period under the mi-
croscope. The sham-radiated cells grew well, demonstrat-
ing the conditions in the chamber were appropriate for the 
cells. The cell number in each field of view was between 
8 and 30.
The cell proliferation rates in the wells were radiation-
dose dependent. The results were similar in the 2 separate 
experiments, and the rates from a representative run are 
shown in Fig. 1. In the sham-radiation wells, the number 
of cells in the fields of view increased by 140% by Day 
3. Using this result as a control, radiation at a dose of 5 
Gy significantly reduced the cell proliferation rate. The 
increase in cell number at Day 3 was less than 50% (p < 
0.01). The higher radiation doses (15 Gy and 25 Gy) totally 
inhibited cell proliferation. The cell number was eventu-
ally reduced by around 20% at Day 3. The differences in 
percentage changes of cell numbers at Day 3 were not sta-
tistically significant between the groups receiving 15- or 
25-Gy doses (p = 0.72), but both groups were significantly 
lower than the group treated with the 5-Gy dose and the 
sham-radiation controls (p < 0.01). The percentage change 
of cell number at Day 3 in the camptothecin-positive con-
trol group was similar between the groups treated with 
15- or 25-Gy doses but significantly lower than the group 
treated with the 5-Gy dose and the sham-control groups 
(p < 0.05).
morphology changes of the cells after irradiation 
The low-density bEnd.3 cells at the time of irradiation 
exhibited a normal endothelial cell morphology with flat-
tened and epithelial appearance, and some were elongated 
like fibroblasts (Fig. 2A and C). In comparison with sham 
radiation–treated cells, the irradiated cells showed distinct 
pseudopodial elongation with little or no spreading of the 
cell body and more cells with increased cytoplasmic vol-
ume. This was particularly apparent at late stages of the 
experiment and with higher radiation doses (Fig. 2C).
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ps externalization and cell death after irradiation
In cells that underwent PS staining using pSIVA, only 
a few green spots could be seen per field of view at the 
beginning of imaging (4 hours after radiation exposure), 
and no significant differences in PS externalization could 
be detected in irradiated cells at any radiation-dose level 
in comparison with sham-radiation control cells (Fig. 2A 
and B). However, the percentages of pSIVA-positive cells, 
represented by the ratio of green spots to cell number in the 
corresponding fields, were significantly higher (p = 0.04) in 
the cells that received a 25- or 15-Gy dose of radiation 24 
hours after treatment (Figs. 2A, 2B, and 3A). This effect 
was sustained until the end of the experiment (3 days), with 
the highest ratios at the last time point (p < 0.01). Radiation 
at 5 Gy did not induce significantly higher PS external-
ization compared with the sham-radiation control at any 
time points (p > 0.15). The effect of camptothecin on cell 
PS externalization was similar to that seen with the 25- 
and 15-Gy radiation doses. However, in comparison with 
radiation-treated cells, the increase in the pSIVA-positive 
cells in the second half of the incubation period was more 
notable in the camptothecin-treated cells. The results from 
a representative run are shown in Figs. 2 and 3.
The percentages of PI-positive cells, represented by 
the ratio of red spots to cell number in the corresponding 
fields, had a similar trend with the pSIVA-positive cells, 
although the values were much lower in all the radiation-
dose groups at all time points (Figs. 2A and 3B). The 
percentages were significantly higher in 25- and 15-Gy 
treated cells at 24 hours after irradiation and later time 
points. In the cells treated with a 5-Gy dose of radiation 
and camptothecin, the percentage of PI-positive cells was 
significantly higher than sham-radiation control cells only 
at the end of the experiment (Figs. 2A and 3B).
Statistical analysis did not show any significant dif-
ferences between 25- and 15-Gy radiation doses in cell 
pSIVA staining and PI staining at any time point. How-
ever, there were significant differences in pSIVA and PI 
staining between 15- and 5-Gy radiation doses at 49 and 
74 hours postirradiation.
cell cycle analysis of the irradiated endothelial cells
Irradiated bEnd.3 endothelial cells were also ana-
lyzed by flow cytometry. Here, the effect of irradiation 
was clearly evident, as even low-dose radiation (e.g., 5 
Gy) resulted in a change in the cells FWD-area versus 
FWD-height dot-plot profile (Fig. 4A). Moreover, even in 
a simple ungated analysis, 15- and 25-Gy radiation doses 
appeared to alter the proportion of cells in G1 versus G2 of 
the cell cycle (Fig. 4A). These doses of radiation also more 
than doubled the number of polyploidy cells by 3 days 
(events right of the 2N peak in Fig. 4A). To confirm these 
results, a proper cell cycle analysis was performed by first 
gating on single cells, defined as cells that had a propor-
tional FWD-height versus FWD-area ratio (region 1; R1, 
blue gate). The cell cycle analysis indicated that 48% of 
the cells had accumulated in the G2 phase of the cell cycle 
after a 25-Gy radiation dose, compared with just 19% in 
nonirradiated cells, with a similar effect after a 15-Gy 
radiation dose (23% G2) (Fig. 4B). Taken together, these 
data indicate that irradiation induces the growth arrest of 
bEnd.3 cells, with cells accumulating in the G2 phase of 
the cell cycle and with many cells becoming senescent as 
evident by their polyploidy state.
Fig. 1. Cell proliferation curves after exposure to radiation doses of 0, 5, 15, and 25 Gy. The results are expressed as the percent-
age changes of cell number relative to the initial cell number (4 hours), at different time points after irradiation in the relevant fields 
of view. The arrows indicate the time point where the differences in each group with sham-radiation control cells became statisti-
cally significant. C = sham-radiation control; CT = camptothecin.
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discussion
The effect of ionizing radiation on cells is well docu-
mented.24 It includes 2 main aspects: direct cellular dam-
age through modification of macromolecules such as 
DNA and proteins, and indirect cellular damage through 
production of reactive oxidative species.2 Depending on 
the level of damage, cell cycle arrest, DNA repair, senes-
cence, or apoptosis will be initiated.6 Endothelial cells are 
very sensitive to radiation.8 Our previous studies revealed 
proinflammatory and thrombotic molecule changes on the 
surface of brain endothelial cells after ionizing radiation 
exposure.25 The current study further confirmed that ra-
diation at clinically relevant doses (15 and 25 Gy) has a 
clear effect on the bEnd.3 cells. Radiation at both doses 
totally inhibited the growth of the cultured cells, caused 
growth arrest and remarkable morphological changes, and 
induced significant PS externalization. Although the lower 
radiation dose (5 Gy) did not cause clear morphological 
changes or induce significant PS externalization, it clearly 
inhibited the growth of these cells.
Live-cell imaging takes advantage of the ability to 
sample data from essentially the same cells (identical 
fields of view) at different points in time postradiation ex-
posure. This allowed for easy tracking of proliferation of 
individual cells but only for a limited number of cells (i.e., 
those within the imaged fields). However, flow cytom-
etry analysis permits analysis of significantly more cells 
(10,000 cells or more) and additionally defined that irra-
diation caused the accumulation of cells in the G2 phase 
of the cell cycle. The results are consistent with previous 
reports on ionizing radiation effect on cells.19,23,41 Thus, the 
radiation induced a growth inhibition that was largely due 
to cell cycle inhibition, senescence, and/or cell death.
Since the distribution of PS on the cell surface is un-
even and apoptotic cells may break into several pieces,46 
Fig. 2. Cell photomicrographs. a and b: Overlap images of pSIVA-positive and PI-positive cells under bright-field microscopy 
and pSIVA-positive spots only (green channel) (B) taken at 4, 24, 49, and 74 hours after exposure to 0-, 5-, 15-, and 25-Gy doses 
of radiation or treated by 10 µM camptothecin. c: Cell morphology at 74 hours after cells received sham radiation (left) or a 25-Gy 
radiation dose (right). Scale bar = 10 µm.
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1 cell may have several PS- or PI-positive staining spots. 
The ratio in Fig. 3 might not exactly represent the percent-
age of positive cells but should be an indicator of the de-
gree of PS externalization or cell death.
These results may have physiological relevance in 
understanding the effect of radiosurgery on AVMs. The 
cellular changes of the endothelium in AVMs may be in-
volved in the obliteration process after radiosurgery. The 
PS expressed on the endothelial cell surface has the poten-
tial to induce thrombus formation.5 Of more immediate 
clinical relevance, the molecule may also represent a valid 
radiation-induced marker for vascular targeting, although 
more work is required to understand its detailed expres-
sion profile after irradiation. Detection of PS expression 
on AVM endothelium after radiosurgery in a rat AVM 
model, using an in vivo imaging technique, is underway 
in our laboratory. Preliminary data suggest that selective 
induction of PS externalization by ionizing radiation on 
endothelium of AVM tissues can be achieved in vivo (data 
not shown).
This study did not find obvious differences in biologi-
cal effects of 15- and 25-Gy radiation doses on the bEnd.3 
cells in cell proliferation, morphological changes, and PS 
externalization. The results suggest that the dose of 15 Gy 
may be adequate to induce the necessary changes in en-
dothelial cells for vascular targeting. However, this does 
not mean a 15-Gy dose of radiation is enough for vascu-
lar obliteration in AVMs. Clinical work has demonstrated 
that a margin dose of 16–25 Gy is necessary to achieve 
a satisfactory occlusion rate.10,44 More work with smaller 
titrations of radiation doses and larger animal numbers 
per group is required to find the optimal radiation dose for 
vascular targeting. Given that high doses of radiation, in-
cluding current clinical doses, can lead to off-target effects 
and late radiation necrosis,27 it would be clinically very 
significant if lower radiation doses could induce sufficient 
molecular changes on the endothelial surface for vascular 
targeting.
Live-cell imaging can monitor molecular changes on 
the cell surface in real time without the need to process 
the cells except for the addition of the dyes into the cul-
ture medium. It is designed to observe the same sets of 
cells in each field of view at different time points, elimi-
nating the experimental errors caused by the variation 
among the cells. It also has the capacity to monitor the 
changes of a single cell. Up to a few hundred fields of 
view across the cell culture plate can be monitored in just 
1 experiment. With the radiation dose designed to deliver 
the desired doses to different parts or wells of the plate, 
this technique can detect the effects of different radiation 
doses on the cells in real time with just 1 run. However, 
there were some drawbacks with the system that we used. 
The bright-field image quality was affected near the edges 
of the narrow wells, and condensation on the lid altered 
the brightness of the images over time. In this system, the 
environmental chamber lid could not be removed once 
mounted onto the microscope; therefore the culture me-
dium could not be changed during the imaging process, 
limiting the monitoring period to a maximum of 3 days 
in this study. The results cannot reveal whether all the 
PS-positive cells will eventually die or can recover or be 
rescued to normal cells. The expression of PS on the cell 
surface increased with time during the monitoring pe-
riod. No peak expression time was identified. Neverthe-
less, large amounts of information regarding the changes 
of the cells during the monitoring period can be obtained 
if the conditions are carefully controlled and appropriate 
control cells are included in the experiments.
Naturally, it is a limitation of all in vitro investigations 
that the microenvironment for the cultured cells is differ-
ent from the in vivo conditions. There are no other cells to 
interact with these cells, such as macrophages to get rid of 
abnormal cells.21 The cells in vivo do not have the space 
to proliferate. Nevertheless, this in vitro study provides 
valuable insight into what might happen in vivo and, thus, 
forms a strong foundation for designing in vivo work in 
the future.
conclusions
Ionizing radiation causes remarkable cellular changes 
in endothelial cells. Significant PS externalization is in-
duced by radiation at doses of 15 Gy or higher, concomi-
tant with a block in the cell cycle. Radiation-induced 
markers/targets may have high discriminating power to be 
harnessed in vascular targeting for AVM treatment.
Fig. 3. Bar graphs of colored dot counts to cell number in cell cultures 
stained with pSIVA and PI. a and b: The ratio of pSIVA-positive spots 
(A) and the ratio of PI-positive spots (B) to cell number in the cells 
exposed to 25-, 15-, 5-, and 0-Gy radiation doses, and the cells treated 
with camptothecin at different time points. Asterisk indicates statistically 
significant differences in comparison with 0-Gy controls. h = hour. 
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